- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Caplin Point Laboratories Limited — Important, 08-12-2025: Updates
08-12-2025 | 03:25 pm
08-12-2025 | 03:25 pm
Caplin Point's subsidiary, Caplin Steriles, secured USFDA approval for Acetaminophen Injection. This generic drug, targeting pain and fever, recorded US sales of approximately $86 million (₹713.8 Cr) in the past year, opening a significant market opportunity.
No comments yet. Be the first to comment!